Impact of radiation therapy on survival in patients with triple‑negative breast cancer

  • Authors:
    • Lauren T. Steward
    • Feng Gao
    • Marie A. Taylor
    • Julie A. Margenthaler
  • View Affiliations

  • Published online on: November 22, 2013     https://doi.org/10.3892/ol.2013.1700
  • Pages: 548-552
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Triple‑negative breast cancer (TNBC) has a poorer prognosis compared with other sub-groups. In the current study, survival associated with locoregional treatment of females with TNBC was investigated. Specifically, 468 patients with stage I‑III TNBC treated between 2002 and 2009 were identified. Data included patient and tumor characteristics, treatment received and survival. Data were compared using χ2 and Fisher's exact tests, as well as MANOVA. Kaplan‑Meier curves were generated. The study cohort had a mean age of 54±13 years old with a mean follow‑up period of 51±21 months. Of 468 patients, 249 (53%) underwent lumpectomy, 63 (14%) underwent simple mastectomy (SM) and 156 (33%) underwent modified radical mastectomy (MRM). Overall, 263 (56%) received adjuvant radiation, including 178/249 (71%) following lumpectomy, 13/63 (21%) following SM and 72/156 (46%) following MRM (P<0.0001). Following control for potential confounders in univariate tests, adjuvant radiation was associated with improved overall survival in the total cohort (HR, 0.46; 95% CI, 0.31‑0.68; P=0.0001). When comparing survival by surgical type, receipt of adjuvant radiation significantly improved survival in the lumpectomy group (HR, 0.30; 95% CI, 0.16‑0.58; P=0.0004), but was not associated with improved survival in the SM group (HR, 0.38; 95% CI, 0.05‑3.04; P=0.36) or in the MRM group (HR, 0.79; 95% CI, 0.46‑1.34; P=0.38). The survival benefit of adjuvant radiation in these TNBC patients is attributed to those undergoing breast‑conserving therapy. There was no benefit in either mastectomy group. These data warrant validation from prospective trials, in order to develop tailored locoregional treatment for patients with TNBC.
View Figures
View References

Related Articles

Journal Cover

2014-February
Volume 7 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Steward LT, Gao F, Taylor MA and Margenthaler JA: Impact of radiation therapy on survival in patients with triple‑negative breast cancer. Oncol Lett 7: 548-552, 2014
APA
Steward, L.T., Gao, F., Taylor, M.A., & Margenthaler, J.A. (2014). Impact of radiation therapy on survival in patients with triple‑negative breast cancer. Oncology Letters, 7, 548-552. https://doi.org/10.3892/ol.2013.1700
MLA
Steward, L. T., Gao, F., Taylor, M. A., Margenthaler, J. A."Impact of radiation therapy on survival in patients with triple‑negative breast cancer". Oncology Letters 7.2 (2014): 548-552.
Chicago
Steward, L. T., Gao, F., Taylor, M. A., Margenthaler, J. A."Impact of radiation therapy on survival in patients with triple‑negative breast cancer". Oncology Letters 7, no. 2 (2014): 548-552. https://doi.org/10.3892/ol.2013.1700